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Background: Biofilm formation is associated with various aspects of bacterial and fungal infection. This study was
designed to assess the impact of diverse natural polyelectrolytes, such as DNA, F-actin, neurofilaments (NFs), vimentin
and purified Pf1 bacteriophage on biofilm formation and swarming motility of select pathogens including
Pseudomonas aeruginosa associated with lung infections in CF patients.
Results: The bacteriophage Pf1 (1 mg/ml) significantly increased biofilm mass produced by Pseudomonas aeruginosa
P14, Escherichia coli RS218 and Bacillus subtilis ATCC6051. DNA, F-actin, NFs and Pf1 also increased biofilm mass of the
fungal C. albicans 1409 strain. Addition of F-actin, DNA or Pf1 bacteriophage to 0.5% agar plates increased swarming
motility of Pseudomonas aeruginosa Xen5.
Conclusions: The presence of polyelectrolytes at infection sites is likely to promote biofilm growth and bacterial
swarming.
Keywords: Bacteria, C. albicans, Filamentous bacteriophages, DNA, F-actin, Biofilm massBackground
Bacterial biofilm, a complex community of surface-
associated cells surrounded by a self-produced polymer
matrix consisting mostly of polysaccharides and DNA can
form at infection sites and promote chronic infection [1–3].
Biofilm increases bacterial resistance to the host immune
system, provides a place for development of resistant mi-
croorganisms and is associated with increased resistance to
exogenous antibiotic treatment [4–6]. Therefore, once
established, biofilm infections are nearly impossible to
eradicate [7]. Biofilm formation involves the production of
an extracellular matrix, but the composition of this matrix
is not well defined. In Pseudomonas aeruginosa PA14,
decreased production of extracellular polymers reduces
static biofilm development [8]. An increasing number of
studies support the hypothesis that DNA, F-actin, and
possibly other filamentous polymers released from host* Correspondence: buckirobert@gmail.com
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sis, trigger genetic changes in planktonic bacteria that ini-
tiate the formation of biofilm [9, 10]. Extracellular DNA
and F-actin have been shown to function as a structural
support for bacterial biofilm architecture [4, 11, 12] and
have been proposed as therapeutic targets to prevent bio-
film growth [5, 13]. Culturing Pseudomonas aeruginosa
(PA) in settings that include neutrophils enhances forma-
tion of biofilms by stimulating the expression of alginate
[5]. Recently, extracellular DNA was found to smooth the
progress of efficient traffic flow of PA cells throughout the
complex matrix of biofilm by maintaining coherent cell
alignment, thereby avoiding traffic jams and ensuring an
efficient supply of cells to the migrating front [14]. How-
ever, biofilm formation and swarming by clinical isolates
of PA were found to be negatively associated [15]. Another
consequence of negatively-charged polymers such as DNA
and F-actin present at infection sites results from their
ability to bind and inactivate host-derived cationic antibac-
terial molecules [16, 17]. Therefore, poly-anionic filament-
ous viruses produced by Pseudomonas, which are
important for the virulence of these pathogens in humans,
might inactivate host antibacterial molecules by similar
mechanisms. The PA strain PAO1 strongly up-regulatesicle distributed under the terms of the Creative Commons Attribution License
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mation, and Pf1-like virions are present at 100 to 1000
fold higher levels in biofilms when compared with plank-
tonic PA cultures [18]. The Pf1 phage exists largely as
bundles of long filamentous phages extending from the
bacterial surface [19]. Bundle formation was previously
found to be mediated by polyvalent counterions, including
cationic host defense molecules [20]. A repeatable pattern
of cell death and lysis that occurs in biofilms during the
normal course of development is also phage-dependent,
and phage-mediated cell death is an important mechanism
of differentiation inside microcolonies that facilitates disper-
sal of a subpopulation of surviving cells [21]. This report in-
dicates that addition of diverse natural polyelectrolytes,
including purified Pf1 bacteriophage, to different bacteria
or Candida albicans cultures results in increased biofilm
formation. The effects of Pf1 on biofilm formation by bac-
terial strains that it cannot infect suggests that the physico-
chemical properties of Pf1 and similar polyelectrolytes,
rather than any specific biological effect of the bacterio-
phage on the bacteria is required for it to support biofilm
formation by different microorganisms.
Results and discussion
Polyelectrolyte-induced formation of microorganisms’
biofilm
In agreement with previous reports [5, 13] F-actin in-
creased biofilm formation by PA PAO1 on glass (Fig. 1a
and b). Increased chemiluminescence of PA Xen5 bac-
teria culture after 48 h growth in the presence of F-actin
or DNA was observed (Fig. 1b: rows 1-control, 2,3,4- in-
creasing concentration of F-actin; 5,6,7—increasing con-
centration of DNA). DNA staining with YOYO-1
revealed an increased concentration of DNA in S. aureus
Xen29 biofilm formed in the presence of exogenous
DNA (Fig. 1d). This observation suggests that bacteria
might use their own and likely other species’ extracellu-
lar DNA to form a biofilm matrix. Increased attachment
of PA PAO1 to the cytoskeleton fraction of A549 cells
attached to the coverglass surface after Triton x-100
treatment indicates that bacteria are able to bind the F-
actin network (Fig. 1e and f). Compared to DNA and Pf1,
F-actin has a stronger stimulatory effect on biofilm mass of
PA Xen5 and S. aureus Xen29 (Fig. 2). Among all tested
bacteria strains, the largest increase in biofilm production
was observed after 48 h for B. subtilis growth in the pres-
ence of 0.25 and 1 mg/ml Pf1 (p < 0.001) (Fig. 3b). A sta-
tistically significant increase in biofilm formation was also
observed at 48 h in PA P14 culture after addition of 0.25
and 1 mg/ml Pf1 (p < 0.05 and p < 0.001 respectively), in E
coli MG1655 culture with addition of 1 mg/ml Pf1 (p <
0.001) and E.coli RS218 culture with addition of 0.25 and
1 mg/ml Pf1 (p < 0.05 and p < 0.001 respectively) (Fig. 3).
The observed differences between the amounts of biofilmformed in the presence of Pf1 bacteriophage for different
bacterial strains might be a result of growth rate differences.
DNA, F-actin, neurofilaments and vimentin are all an-
ionic polyelectrolyte filaments present within the cellular
and extracellular space, that have large net negative
charge densities distributed over their surfaces and all
promote biofilm formation (Figs. 1, 2 and 3 and data not
shown). However, there are some differences between
their activity that may result from filament properties or
the growth of different bacteria strains. Neurofilaments
have little effect on PA Xen5 biofilm formation com-
pared to their effect on S. aureus Xen29, which is more
than doubled in the presence of neurofilaments at a con-
centration of 0.1 mg/ml. Vimentin slightly increases bio-
film formation of both PA Xen5 and S. aureus Xen29
(data not shown). Polyelectrolyte-induced biofilm forma-
tion was also observed for the fungus C. albicans 1409,
which is a frequent cause of fungal infection in humans.
The fungal biofilm matrix is mostly produced by the
fungal cells themselves and is composed of different
types of biopolymers [22]. As shown in Fig. 4, DNA, Pf1,
F-actin and NFs all increase the formation of C. albicans
biofilm. Among these polyelectrolytes, the strongest ac-
tivity was observed for DNA, Pf1, F-actin, and NFs
(Fig. 4). At the tested concentration range (0.1-1 mg/
ml) NFs reveal the potential to promote C. albicans bio-
film formation only at low concentrations. At a concen-
tration greater than 0.5 mg/ml, NFs decrease the
amount of biofilm formed, an effect that might be re-
lated to their high negative charge density. At a high
concentration NFs might function as neutrophil extra-
cellular traps (NETs).
Increase of P. aeruginosa swarming activity in the
presence of polyelectrolytes
Bacterial swarming motility and production of exopoly-
saccharides both contribute to biofilm formation, yet it
is unclear how bacteria coordinate these two processes
[23]. For some bacteria, the ability to swarm positively
correlates with production of exopolysaccharides [24]. In
contrast, alginate oligomers (OligoG) were found to bind
to the bacterial surface, modulate surface charge, induce
microbial aggregation, and inhibit swarming motility
[25]. Figure 5 shows the morphology of a P. aeruginosa
Xen5 biofilm that develops in the presence of different
biopolymers. At the macroscopic level, a more fragmen-
ted pattern of growth was observed in the presence of
F-actin, compared to uniform growth in DNA- or Pf1-
containing samples. As indicated by the arrow in Fig. 5,
on the edges of the biofilm where the swarming assures
spreading of bacteria, more rounded structures less than
10 μm in size are observed in substrates containing bio-
polymers compared to control substrates. Quantitative
analysis of biofilm indicates that all tested biopolymers
Fig. 1 Bacterial biofilm formation in the presence of F-actin and DNA. a Arrows indicate F-actin filaments stained with rhodamine-phalloidin and
attached to a glass slide coated with poly-Lysine (0.1% water solution). b Biofilm mass of Pseudomonas aeruginosa PAO1 formed in the presence
of F-actin. c Chemiluminescence of Pseudomonas aeruginosa Xen5 48 h after bacteria addition to LB broth (row 1) containing F-actin (rows 2, 3, 4) or
DNA (rows 5, 6, 7) at concentrations of 0.01, 0.05 and 0.1 mg ml −1 respectively. d DNA staining (YOYO-1) of Staphylococcus aureus Xen29 biofilm after
48 h growth with and without the presence of DNA. e F-actin filaments of lung epithelial A549 cytoskeleton stained with rhodamine-phalloidin (cells
were treated with 0.01% Triton X-100 for 10 min and washed 3x with PBS before staining). f Pseudomonas aeruginosa PAO1 cells preferentially attached
to the cytoskeleton of A549 cell remnants
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biopolymers, there is a higher average increase of
swarming area for substrates containing DNA than F-
actin or Pf1 at the higher concentrations (0.1 mg/ml). In
agreement with our study, recent results indicate that
among the tested swarming mutants, a large range of bio-
film formation levels was observed [26].Lower mass of biofilm formed in the presence of DNase I
Two clinically important biofilm-forming bacterial path-
ogens, PA and S. aureus were used to assess the effects
of DNAse I and cationic antibacterial agents on biofilm
mass. Addition of Pulmozyme (DNAse I) at 0.5 μg/ml
significantly decreases the biofilm mass of both patho-
gens grown for 48 h with and without DNA (p < 0.01).
Fig. 2 F-actin, DNA and Pf1 bacteriophages increase Staphylococcus aureus Xen29 and Pseudomonas aeruginosa Xen5 biofilm formation. Panels
a and b indicate biofilm mass assessed with crystal violet staining at 24 and 48 h time points. *Significantly increased compared to control
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was found to reduce adhered microflora and decrease
dental plaque formation [27]. The combination of
DNase I and poly(aspartic acid) decreased PA biofilm
formed in the presence of activated neutrophils by 79.2%
on hydrogel contact lenses [13], and disrupted mature
PA biofilm [4]. In our experimental settings, poly(aspar-
tic acid) decreased biofilm formation but the effect did
not reach a statistically significant level (data not
shown). This difference might potentially be associated
with the length of polymer used. On the other hand, in
accordance with previous observations that the polyca-
tionic antimicrobial peptide LL-37 blocks biofilm forma-
tion at concentrations below its MIC, [28] decreased
biofilm mass of both pathogens in the presence of LL-37
peptide (p < 0.001) was observed. A similar decrease was
found in the presence of the cationic antibacterial ster-
oid ceragenin CSA-13 (Fig. 6).Discussion
Accumulation and death of neutrophils recruited in re-
sponse to pathogen invasion and tissue destruction re-
lease various negatively-charged biopolymers including
DNA, vimentin, and F-actin. Destruction of neuronal
cells can be expected to release NFs in addition to F-
actin and DNA, whereas damaged muscle cells might
predominantly release actin. Bacteria also support the
accumulation of extracellular anionic biopolymers since
they can release exopolysaccharides, bacterial DNA, as
well as different filamentous phage. A growing body of
evidence indicates that these biopolymers can interfere
with host immunoresponse to infections. Extracellular
DNA (eDNA) is a major structural component in many
biofilms of pathogenic bacteria [1, 29]. Additionally, the
functional DNA binding-uptake system that can be
inhibited by the presence of DNase l [9], DNA-induced
changes in gene expression [30], and sphingomyelinase-
Fig. 3 Pf1-mediated increase of biofilm formation. Biofilm formation of Pseudomonas aeruginosa P14 (panel a), Bacillus subtilis ATCC 6051 (panel b),
Escherichia coli MG1655 (panel c) and Escherichia coli RS218 (panel d) in the presence of Pf1. Biofilm mass was assessed using crystal violet staining at
24 and 48 h time points. *Significantly increased compared to control
Bucki et al. BMC Microbiology  (2015) 15:117 Page 5 of 10mediated cross-linking of eDNA in the biofilm skeletal
framework [31] are all involved in biofilm formation by
different bacterial pathogens. Results of our study indi-
cate that the ability to stimulate biofilm formation might
be a common feature of negatively charged biopolymers,
including Pf1-like phages expressed by PA strains prefer-
entially infecting CF patients. However, there are con-
flicting interpretations as to whether production of the
filamentous phage virions encoded within P. aeruginosa
as they colonize the airway increase the virulence of
P. aeruginosa strains. The increased production of bio-
film in the presence of Pf1 suggests that phage expres-
sion should be considered as a factor that increases the
virulence of Pseudomonas.
Determining the relevant concentration range of phage
and other polyelectrolytes is guided by several consider-
ations. Infected, purulent body fluids such as cystic fi-
brosis sputum can contain as much as 50 mg ml−1 DNA
and 10 mg ml−1 F-actin. Since Pf1 is not lytic and dif-
fuses very slowly from its site of production, the relevant
virus concentration is that adjacent to the bacteria, as
seen in [19]. Quantitative studies of the rate or extent ofPf1, Pf4, or Pf5 production by Pseudomonas strains have
not yet been reported, but E. coli can produce 830 copies
of the structurally similar 800 nm long filamentous
phage M13 per hour [32]. Making the conservative esti-
mate that a 0.5 μm x 2 μm cylindrical Pseudomonas pro-
duces 800 viruses extending from the bacterial surface,
and using the fact that a polymer of length 2 μm and
persistence length 2 μm has an end-to-end distance of
1.7 μm [33], the local concentration of Pf1 within the
zone 1.7 μm away from the bacterial surface is approxi-
mately 1 mg ml−1. This concentration is within the range
at which Pf1 promotes biofilm growth. Therefore [Pf1]
between 0.1 and 5 mg ml−1 is likely to be relevant to a
purulent setting. These findings also indicate that the
physicochemical properties of filamentous bacterio-
phage, and its concentration, rather than the ability of
Pf1 to infect and propagate in bacteria, are sufficient to
promote biofilm growth. Pf1 has a very similar size,
shape, and charge density as F-actin and aggregates simi-
larly with multivalent cations. These features might ex-
plain the strong ability of both polymers to induce biofilm
formation [5, 34], as well as that of neurofilaments and
Fig. 4 Biofilm formation of C. albicans. Increase of C. albicans 1409 biofilm formation in the presence of DNA (panel a), F-actin (panel b), Pf1
(panel c) and NFs (panel d) (n = 6). *Significantly different compared to control
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an increase of C. albicans biofilm formation induced by its
own DNA as well as DNA released from bacteria [12, 36],
we observed that DNA and other natural polyelectrolytes
such as F-actin, Pf1 and NFs can all stimulate this process.
The dose-dependent effect recorded for NFs (concentra-
tions above 0.5 mg/ml resulted in decreased biofilm for-
mation) was previously reported for DNA [36].
The effect of anionic biopolymers to promote biofilm
formation may depend on their effect on swarming mo-
bility. Many bacteria move in groups, in a mode de-
scribed as swarming to colonize surfaces and form a
biofilm to survive external stresses, including exposure
to antibiotics [37]. Considering the possibility of charge-
driven interactions, antibiotic resistance might result from
the ability to sequester positively-charged antibiotics by
negatively-charged polymeric components [17, 38] of the
biofilm network before the antibiotics reach and insert
into bacterial cells. This mode of bactericidal agent inacti-
vation affects natural host defense cationic peptides such
as cathelicidin LL-37.Conclusion
The presence of polyelectrolytes at infection sites such
as DNA, F-actin, neurofilaments and Pf1 bacteriophage
is likely to promote biofilm formation. However, the
mass of developing biofilm in the presence of the same




Cetrimide Agar (Pseudomonas selective agar base) and
deoxyribonucleic acid from herring sperm were from
Sigma. Luria-Bertani broth (LB) and tryptic soy broth
(TSB) were from DIFCO (Sparks, MD). Dulbecco’s Modi-
fied Eagle media (DMEM) was from GIBCO, (Grand
Island, NY). Fetal bovine serum was from Hyclone, (Logan,
UT). PA Xen 5 and S. aureus Xen29 strains engineered
through conjugation and transposition of a plasmid carry-
ing transposon Tn5 luxCDABE were purchased from
Caliper Life Science Inc. (CA, USA). B. subtilis ATCC6051,
E. coli MG1655, E. coli RS218 and C. albicans 1409 was
Fig. 5 Morphology of Pseudomonas aeruginosa Xen5 biofilm growth on agar with addition of DNA, F-actin and Pf1 bacteriophage. In the presence of
different biopolymers (0.1 mg/ml), after 16 h of bacterial growth, the swarming edges show some similar features (they are more diffuse and less
defined; panel a-d). Developing area of spreading PA biofilm due to swarming activity was assessed using Image Gauge software (panel e).
*Significantly different compared to control
Bucki et al. BMC Microbiology  (2015) 15:117 Page 7 of 10purchased from ATTC collection and Polish Collection of
Microorganism (PCM). High affinity nucleic acid stain
YOYO®-1 was from Life Technologies (Grand Island, NY).
Monomeric G-actin was prepared from acetone powder of
rabbit skeletal muscle [39] and kept in non-polymerizingsolution contained 2 mM TRIS, 0.2 mM CaCl2, 0.5 mM
ATP, 0.2 mM DTT pH 7.4. Actin polymerization was in-
duced by adding 150 mM KCl and 2 mM MgCl2. Neurofi-
laments (NFs) were isolated from bovine spinal cord
according to procedures described previously [40]. Protease
Fig. 6 Biofilm formation in the presence of DNA and DNase I.
Pseudomonas aeruginosa Xen 5 (panel a) and Staphylococcus aureus
Xen 29 (panel b) biofilm at 48 h in 50% LB with DNA 0.25 mg/ml in
the absence/presence of DNase I (0.1–30 μg/ml) and in the presence
of LL-37 or CSA-13 (20 μM each). Inhibitory effect of DNase was
compared to the effect of CSA-13 and LL-37 (n= 4). *Significantly
different compared to control
Bucki et al. BMC Microbiology  (2015) 15:117 Page 8 of 10free, Pf1 bacteriophage strain LP11-92 that was propagated
in P. aeruginosa LA23-99 was from ASLA Biotech Ltd.
(Riga, Latvia).Cell Culture
Human lung epithelial carcinoma cells, line A549, were
cultured in DMEM supplemented with 10% fetal bovine
serum at 37 °C with 5% CO2. Cells were seeded and
allowed to spread for 24–72 h before experiments were
performed. A549 cells were fixed with 4% paraformalde-
hyde (Sigma-Aldrich) for 10 min at room temperature
and subjected to 0.1% solution of TRITON X-100 treat-
ment to expose the cytoskeleton F-actin network. When
required, staining with 1:100 rhodamine-labeled phal-
loidin (Invitrogen) in PBS for 30 min was performed. To
assess bacterial ability to interact with the cytoskeleton,
a suspension of PA PAO1 (105 CFU/ml) was added to
A549 cell remnants for five minutes. Fluorescence and
bacterial attachment were evaluated after 3 washes withPBS, using a LEICA DM IRBE. Images were captured
with a Cool SNAP (HQ) camera (Trenton, NJ, USA).
Biofilm formation
The mass of biofilms was assessed using Crystal Violet
(CV) staining (0.1%) [41] and chemiluminescence inten-
sity measurements as an additional determinant of bio-
film viability [42]. In each experiment an overnight
culture of P. aeruginosa Xen 5, P. aeruginosa PAO1,
P. aeruginosa P14 in TSB or S. aureus Xen 29, B. subtilis
ATCC6051, E. coli MG1655, E. coli RS218 and C. albi-
cans 1409 in LB was diluted to ~ 105 CFU/ml. When re-
quired, bacterial suspensions were placed on glass slides
coated with poly-Lysine/F-actin or in flat bottom PVC
microplates (MP Biomedicals; Solon, OH) sealed with a
gas permeable membrane (USA Scientific; Ocala, FL).
Bacteria or C. albicans were grown in 50% LB broth
with or without F-actin, DNA, NFs, vimentin or Pf1 bac-
teriophage. A stationary biofilm was allowed to form for
24 or 48 h. PA Xen5 and S. aureus Xen29 chemilumin-
escence signals were evaluated using a Fuji Film LAS-
300 system. Densitometry analysis was performed using
Image Gauge (version 4.22) software.
Pseudomonas aeruginosa Xen5 swarming motility
A swarming motility assay was assessed as described previ-
ously [43]. Briefly, 3 μl of bacterial inoculum containing
~108 CFU/ml were placed in the center of 0.5% agar con-
taining modified M9 medium with different concentrations
of F-actin, DNA or Pf1 bacteriophage (0.005–0.1 mg/ml) in
6 well plates. Swarming area was evaluated from images
captured with a Fuji Film LAS-300 system analyzed with
Image Gauge (version 4.22) software.
Statistical analysis
Data are reported as mean ± SD from 3–8 repeats. Dif-
ferences between means were evaluated using the un-
paired Student’s t-test and differences p < 0.05 were
considered statistically significant.Competing interests
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